|
AdvisorShares Pure Cannabis ETF
|
||||||||||||||||||
- Description
- Performance
- Comps
Fundamentals
Valuation
Rating
| YOLO seeks long-term capital appreciation by investing in both domestic and foreign cannabis equity securities. |
| Category | Global Equities |
| Fund Sponsor | AdvisorShares |
| Website | www.advisorshares.com |
| Inception date | Apr 17, 2019 |
| Assets (mns) | $37 |
| Currency | USD |
| Expense ratio | 103 bp |
| Distributions | Annually |
| Regulation | Open-Ended Fund |
| Custodian | |
| Weighting | Market Cap |
| Index replication | |
| Uses derivatives | No |
| Options available | Yes |
| No. of constituents | 17 |
| Wgt avg mkt cap (mns) | $306 |
| Large cap (>$10bn) | 0.0% |
| Mid cap ($2-10bn) | 11.5% |
| Small cap (<$2bn) | 88.5% |
| Developed mkts | 100.0% |
| Emerging mkts | 0.0% |
| ADVISORSHARES PURE US CANNABIS ETF | 56.1 % |
| VILLAGE FARMS INTERNATIONAL, INC. | 15.2 % |
| HIGH TIDE, INC. | 8.4 % |
| CHARLOTTE'S WEB HOLDINGS, INC. | 4.0 % |
| ORGANIGRAM GLOBAL INC | 3.5 % |
| SNDL INC ORDINARY SHARES | 3.2 % |
| CRONOS GROUP INC | 3.1 % |
| AURORA CANNABIS INC | 1.6 % |
| RUBICON ORGANICS INC | 1.5 % |
| TILRAY BRANDS INC | 0.9 % | Total | 97.4 % |
|---|
| CANADA | 30.8 % |
HISTORICAL PERFORMANCE 

| Custom date range | Compare to | ||
| thru |
| Year-to-date | 1 year | 5 years | 10 years | Since Incep. |
| -6.4% | 58.5% | -30.7% | -- | -23.8% |
| versus... | Beta | R-squared |
| S&P500 | 1.43 | 5% |
| MSCI EAFE | 0.92 | 4% |
| MSCI Emg. Mkts. | 0.82 | 5% |
| Recent close | $3.13 |
| 30d moving avg. | $3.06 |
| Annualized volatility | 59.0% |
| Short interest (ETF) | 0.0% |
| Relative strength (RSI) | 53 |
| Avg. volume (thou.) | 35 |
| Turnover | 0.3% |
| Bid/Ask (% of price) | 2.99% |
| ADV underlying (mns) | $101 |
FINDING ALTERNATIVE FUNDS
Below is a list of 13 potential alternatives to the AdvisorShares Pure Cannabis ETF ETF based on the alternatives' overlap in portfolio holdings with YOLO. Consider funds with lower expense ratios and/or higher ALTAR Score™ ratings as possible alternatives.
| Benchmark ticker: | YOLO | Expense: | 103 bp | ALTAR Score™: | -5.7% |
| Ticker | Fund Name |
Overlap1 vs YOLO (%) |
Expense ratio (bp) |
Savings vs YOLO (bp) |
ALTAR Score™ (%) |
ALTAR vs YOLO (%) |
| BSVO | EA Bridgeway Omni Small-Cap Value ETF | 0.0 | 47 | 56 | 7.7 | +13.4 |
| AVSC | Avantis U.S Small Cap Equity ETF | 0.0 | 25 | 78 | 4.7 | +10.3 |
| AVUV | Avantis U.S. Small Cap Value ETF | 0.0 | 25 | 78 | 8.0 | +13.6 |
| EES | WisdomTree U.S. SmallCap Fund | 0.0 | 38 | 65 | 7.9 | +13.6 |
| ONEQ | Fidelity Nasdaq Composite Index ETF | 0.0 | 21 | 82 | 2.9 | +8.5 |
| WSML | iShares MSCI World Small-Cap ETF | 0.0 | 15 | 88 | 5.3 | +11.0 |
| DFAI | Dimensional International Core Equity Market ETF | 0.0 | 18 | 85 | 6.1 | +11.7 |
| IDEV | iShares Core MSCI International Developed Markets ETF | 0.0 | 4 | 99 | 6.0 | +11.7 |
| IXUS | iShares Core MSCI Total International Stock ETF | 0.0 | 7 | 96 | 6.6 | +12.2 |
| DFIS | Dimensional International Small Cap ETF | 0.0 | 39 | 64 | 6.1 | +11.8 |
| SPGM | SPDR Portfolio MSCI Global Stock Market ETF | 0.0 | 9 | 94 | 4.9 | +10.5 |
| DFIC | Dimensional International Core Equity 2 ETF | 0.0 | 23 | 80 | 6.3 | +11.9 |
| DXIV | Dimensional International Vector Equity ETF | 0.0 | 34 | 69 | 6.6 | +12.3 |
1Overlap is the percentage of holdings by weight that are identical. For example, if Fund A has a 2% position in Apple, Inc. (AAPL) and Fund B has a 5% position, their overlapping position in AAPL is 2%.
Content on this tab for subscribers only**
RESULTS & ESTIMATES
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | |
|---|---|---|---|---|---|---|---|
| Sales per share | ** | ** | ** | ** | ** | ** | ** |
| Earnings per share | ** | ** | ** | ** | ** | ** | ** |
Dividends per share ![]() |
** | ** | ** | ** | ** | ** | ** |
| Book value per share | ** | ** | ** | ** | ** | ** | ** |
| Sales per share growth | **% | **% | **% | **% | **% | **% | |
| EPS growth | **% | **% | **% | **% | **% | **% |
| Sales per share growth | **% | **% | **% | **% | **% | **% | |
| EPS growth | **% | **% | **% | **% | **% | **% |
OTHER FUNDAMENTAL METRICS
| Long term EPS growth est. | **% | Debt-to-equity | **x | |
| Asset turnover | **% | Assets-to-equity | **x |
| *Six months ago = 100 |
Content on this tab for subscribers only
VALUATION METRICS
| 2024 | 2025E | 2026E | |
|---|---|---|---|
| Price-to-sales | ** | ** | ** |
| Price-to-earnings | ** | ** | ** |
| Price-to-cash flow | ** | ** | ** |
| Price-to-growth | ** | ** | ** |
| Price-to-book value | ** | ** | ** |
| Yield | ** | ** | ** |
Historical valuation trends
| Forward multiple: |
AdvisorShares Pure Cannabis ETF | |||
| Relative to: |
S&P500 | MSCI EAFE | MSCI Emg. Mkts. | Other ETF: |
AVOID |
| Not worthwhile for most investors. A rating of AVOID is assigned to ETFs with ALTAR Scores in the lowest quintile (the bottom 20%) of their category. Often, funds in this category consist of stocks with little if any history or expectation of profitability, and as a result our fundamentally-driven analysis may not be relevant. |
|
ALTAR Score™
|
MODERN PORTFOLIO THEORY
![]() |
||||||||||||||||||||
CONSENSUS RECOMMENDATIONS: FUND CONSTITUENTS
|
||||||||||||||
